The relationship of the -5, -8, and -24 variant alleles in African Americans to triosephosphate isomerase (TPI) enzyme activity and to TPI deficiency

被引:11
|
作者
Schneider, A
Forman, L
Westwood, B
Yim, C
Lin, J
Singh, S
Beutler, E
机构
[1] Finch Univ Hlth Sci Chicago Med Sch, Dept Pathol, N Chicago, IL 60064 USA
[2] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA USA
[3] Vet Affairs Med Ctr, Lab Serv, N Chicago, IL USA
关键词
D O I
10.1182/blood.V92.8.2959.420k23_2959_2962
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In 424 African-American and 75 white subjects, we found that the -5 (TPI 592 A-->G), -8 (TPI 589 G-->A), and -24 (TPI 573 T-->G) variants in the triosephosphate isomerase (TPI) gene occurred frequently (41.0%) in the African-American subjects but did not occur in the whites. These data suggest that this set of polymorphisms may turn out to be one of the higher-incidence molecular markers of African lineage, a surprising finding because others had reported that these nucleotide substitutions were restricted to a small subset of African Americans who had been characterized as TPI-deficiency heterozygotes. Additionally, we investigated the relationship of these variants to TPI-enzyme activity. Although the variant substitutions (occurring in three haplotypes: -5 alone, -5 -8, and -5 -8 -24) were associated with moderate reduction in enzyme activity, severe-deficiency heterozygotes could not be identified with certainty, and none of the haplotypes were restricted to subjects with marked reduction of enzyme activity. Three subjects were homozygous for the -5 -8 haplotype, a finding inconsistent with the putative role of this haplotype as the cause of a null variant incompatible with life in homozygotes. Despite these findings, the possibility remains that the -5 -8 or -5 -8 -24 haplotypes may in some instances contribute to compound heterozygosity and clinical TPI deficiency. (C) 1998 by The American Society of Hematology.
引用
收藏
页码:2959 / 2962
页数:4
相关论文
共 7 条
  • [1] New insights into the interrelationships of the -5, -8 and -24 mutations with triosephosphate isomerase (TPI) deficiency.
    Schneider, A
    Forman, L
    Westwood, B
    Yim, C
    Lin, J
    BlackstoneGardner, R
    Singh, S
    Beutler, E
    [J]. BLOOD, 1997, 90 (10) : 1200 - 1200
  • [2] A NEW ERYTHROCYTE ENZYME DEFECT WITH HEMOLYTIC ANEMIA - TRIOSEPHOSPHATE ISOMERASE (TPI) DEFICIENCY
    SCHNEIDER, AS
    VALENTINE, WN
    HATTORI, M
    HEINS, HL
    [J]. BLOOD, 1964, 24 (06) : 855 - 856
  • [3] Itavastatin and resveratrol increase triosephosphate isomerase protein in a newly identified variant of TPI deficiency
    VanDemark, Andrew P.
    Hrizo, Stacy L.
    Eicher, Samantha L.
    Kowalski, Jules
    Myers, Tracey D.
    Pfeifer, Megan R.
    Riley, Kacie N.
    Koeberl, Dwight D.
    Palladino, Michael J.
    [J]. DISEASE MODELS & MECHANISMS, 2022, 15 (05)
  • [4] Membrane fluidity, active calcium transport and acetylcholinesterase activity of red cells in triosephosphate isomerase (TPI) deficiency
    Hollan, S
    Magocsi, M
    Farkas, T
    Horanyi, M
    [J]. BLOOD, 1995, 86 (10) : 2505 - 2505
  • [5] Hereditary hemolytic anemia with triosephosphate isomerase (TPI) deficiency: Assignment of the known mutation sites to functional molecular domains of the enzyme protein.
    Halfman, C
    Schneider, A
    [J]. FASEB JOURNAL, 1997, 11 (03): : 3078 - 3078
  • [6] Missense variant in TPI1 (Arg189Gln) causes neurologic deficits through structural changes in the triosephosphate isomerase catalytic site and reduced enzyme levels in vivo
    Roland, Bartholomew P.
    Richards, Kristen R.
    Hrizo, Stacy L.
    Eicher, Samantha
    Barile, Zackery J.
    Chang, Tien-Chien
    Savon, Grace
    Bianchi, Paola
    Fermo, Elisa
    Ricerca, Bianca Maria
    Tortorolo, Luca
    Vockley, Jerry
    VanDemark, Andrew P.
    Palladino, Michael J.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2019, 1865 (09): : 2257 - 2266
  • [7] TRIOSEPHOSPHATE ISOMERASE DEFICIENCY - HEMOLYTIC-ANEMIA, MYOPATHY WITH ALTERED MITOCHONDRIA AND MENTAL-RETARDATION DUE TO A NEW VARIANT WITH ACCELERATED ENZYME CATABOLISM AND DIMINISHED SPECIFIC ACTIVITY
    EBER, SW
    PEKRUN, A
    BARDOSI, A
    GAHR, M
    KRIETSCH, WKG
    KRUGER, J
    MATTHEI, R
    SCHROTER, W
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 1991, 150 (11) : 761 - 766